Ticker: LEXX

Lexaria Bioscience Corp. (NASDAQ: LEXX) has recently released its quarterly report for the period ending May 31, 2025, revealing a mix of financial trends that reflect the company's ongoing activities and challenges. Financial Highlights: Revenue: $531,923 (up from $380,278 in 2024). Net loss: $...